Analysts have been under intense pressure in recent months as they try to make sense of the impact of geopolitical and economic uncertainty on companies like Dr Martens (LON:DOCS).
As one of just 200 shares in the UK market valued at more than £1.0 billion (its market cap is £2,389m), Dr Martens is well covered by analysts who will know better than most how the economic conditions will affect it.
So how have the shares performed over the past year?
On a 12 month basis, the Dr Martens share price has seen an absolute move of -45.9%. On a relative basis - which take into account the movement of the wider market - the shares have moved by -44.4% over the past year and by -31.6% over the past six months.
But what now?
Do analysts rate it as a buy, sell or hold?
Regardless of recent performance, the main question is what the future holds. In uncertain economic conditions, it's often difficult to get an accurate view. The good news is that analysts generally have a solid understanding of the market's biggest businesses, so they are well-placed to make predictions. That shows up in their Buy, Hold and Sell recommendations.
Among the analysts covering Dr Martens, there are currently:
2 Buy recommendations
1 Hold recommendations
0 Sell recommendations
With this kind of information, it's possible to start forming a view about the outlook for any share. A combination of recent price performance and analyst recommendations gives you a flavour of whether the market is expecting a bright future - or whether there are causes for concern.
What does this mean for potential investors?
Dr Martens is one of the most closely watched shares in the market. But while price trends and broker recommendations can give you an idea about the sentiment around a stock, they can't tell you everything.
To get a better understanding of the overall investment case, it's worth doing some investigation yourself. Indeed, we've identified some areas of concern with Dr Martens that you can find out about here.